OCT 23, 2026 · JOURNAL ARTICLE
Targeting ERO1α triggers tumor immunosurveillance in triple-negative breast cancer
Redox Biology
Triple-negative breast cancer (TNBC) remains a highly aggressive malignancy with limited responsiveness to immune checkpoint blockade. Here, we identify endoplasmic reticulum oxido